Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary P Bronner

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Gastrointestinal Endoscopy|July 24, 2007
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasiaBergein F Overholt, Kenneth K Wang, J Steven Burdick, et al.
Clinical and Translational Medicine|August 30, 2021
Proteome heterogeneity and malignancy detection in pancreatic cyst fluidsSheng Pan, Randall E Brand, Lisa A Lai, et al.
Cancer Research|September 28, 2011
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and DLaurent Dumartin, Hannah J Whiteman, Mark E Weeks, et al.
Oncotarget|October 13, 2015
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitisMarah C Runtsch, Ruozhen Hu, Margaret Alexander, et al.
The American Journal of Surgical Pathology|November 10, 2011
Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systemsDeepa T Patil, John R Goldblum, Lisa Rybicki, et al.
American Journal of Clinical Pathology|September 9, 2005
Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagusMarie E Robert, Mary Kay Washington, Jeffrey R Lee, et al.
Gastroenterology|November 11, 2008
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasiaMary P Bronner, Bergein F Overholt, Shari L Taylor, et al.
NPJ Precision Oncology|May 22, 2026
Molecular features unique to circulating tumor DNA enable the tumor-naïve liquid biopsy of glioblastomaHunter R Underhill, Drew L Sellers, Sabine Hellwig, et al.
Nature Cell Biology|August 17, 2017
Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolismJohn C Schell, Dona R Wisidagama, Claire Bensard, et al.
The American Journal of Surgical Pathology|November 23, 2023
Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease: A 13 Center Correlative StudyNatalie Patel, Daniel A Leffler, Abdulbaqi Al-Toma, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Gastrointestinal Endoscopy|July 24, 2007
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasiaBergein F Overholt, Kenneth K Wang, J Steven Burdick, et al.
Clinical and Translational Medicine|August 30, 2021
Proteome heterogeneity and malignancy detection in pancreatic cyst fluidsSheng Pan, Randall E Brand, Lisa A Lai, et al.
Cancer Research|September 28, 2011
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and DLaurent Dumartin, Hannah J Whiteman, Mark E Weeks, et al.
Oncotarget|October 13, 2015
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitisMarah C Runtsch, Ruozhen Hu, Margaret Alexander, et al.
The American Journal of Surgical Pathology|November 10, 2011
Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systemsDeepa T Patil, John R Goldblum, Lisa Rybicki, et al.
American Journal of Clinical Pathology|September 9, 2005
Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagusMarie E Robert, Mary Kay Washington, Jeffrey R Lee, et al.
Gastroenterology|November 11, 2008
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasiaMary P Bronner, Bergein F Overholt, Shari L Taylor, et al.
NPJ Precision Oncology|May 22, 2026
Molecular features unique to circulating tumor DNA enable the tumor-naïve liquid biopsy of glioblastomaHunter R Underhill, Drew L Sellers, Sabine Hellwig, et al.
Nature Cell Biology|August 17, 2017
Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolismJohn C Schell, Dona R Wisidagama, Claire Bensard, et al.
The American Journal of Surgical Pathology|November 23, 2023
Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease: A 13 Center Correlative StudyNatalie Patel, Daniel A Leffler, Abdulbaqi Al-Toma, et al.
Pageof 12